BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28533659)

  • 1. BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis.
    Kelleher FC; Callaghan G; Gallagher C; O'Sullivan H
    World J Gastroenterol; 2017 May; 23(17):3022-3029. PubMed ID: 28533659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
    Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
    Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
    Srivastava A; Redston M; Farraye FA; Yantiss RK; Odze RD
    Am J Surg Pathol; 2008 Feb; 32(2):296-303. PubMed ID: 18223333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis.
    Suzuki H; Yamamoto E; Yamano HO; Nakase H; Sugai T
    Digestion; 2019; 99(1):33-38. PubMed ID: 30554192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and histologic considerations in the assessment of serrated polyps.
    Yang HM; Mitchell JM; Sepulveda JL; Sepulveda AR
    Arch Pathol Lab Med; 2015 Jun; 139(6):730-41. PubMed ID: 26030242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal serrated adenocarcinoma.
    Mäkinen MJ
    Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile.
    Dehghanizadeh S; Khoddami V; Mosbruger TL; Hammoud SS; Edes K; Berry TS; Done M; Samowitz WS; DiSario JA; Luba DG; Burt RW; Jones DA
    PLoS One; 2018; 13(3):e0192499. PubMed ID: 29590112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
    Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
    Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
    Rau TT; Agaimy A; Gehoff A; Geppert C; Jung K; Knobloch K; Langner C; Lugli A; Groenbus-Lurkin I; Nagtegaal ID; Rüschoff J; Saegert X; Sarbia M; Schneider-Stock R; Vieth M; Zwarthoff EC; Hartmann A
    Virchows Arch; 2014 Jun; 464(6):663-72. PubMed ID: 24728704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and molecular correlations in traditional serrated adenoma.
    Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
    J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.